UBS Group’s Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock REVH Stock Holding History

UBS Group’s Portfolio REVH Stock Details REVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,139	Closed	-$11K	–	11764
2022 Q3	$11K	Sell	1,139 -1,179	-51%	-$11.6K	﹤0.01%	8385
2022 Q2	$23K	Buy	2,318 +160	+7%	+$1.56K	﹤0.01%	6729
2022 Q1	$21K	Sell	2,158 -51	-2%	-$497	﹤0.01%	7426
2021 Q4	$22K	Buy	+2,209	New	+$21.6K	﹤0.01%	7758
2021 Q3	–	Sell	-556	Closed	-$5K	–	10471
2021 Q2	$5K	Buy	+556	New	+$5.48K	﹤0.01%	8611

UBS Group's REVH Position: Q4 2022 in Review

UBS Group sold out of Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock (REVH) in Q4 2022, closing a stake of 1,139 shares — an estimated $11K sold.

UBS Group first reported a position in REVH in Q2 2021 and held it in 5 quarters. The position peaked at $23K in Q2 2022. 0 funds tracked by Wall St. Rank hold REVH as of Q4 2022.

UBS Group reported no remaining Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock position as of Q4 2022 after selling out during the quarter.
UBS Group sold 1,139 Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock shares in Q4 2022, an estimated $11K.
UBS Group first reported a position in Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock in Q2 2021 and held it in 5 quarters.
UBS Group's Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock position peaked at $23K in Q2 2022.
0 funds tracked by Wall St. Rank held Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.